H2020Doctoral network2019–2023

TubInTrain · Tuning Tubulin Dynamics and Interactions to Face Neurotoxicity: a Multidisciplinary Approach for Training and Research

Horizon 2020 — Marie Skłodowska-Curie Actions

Duration
2019-10-01 → 2023-09-30
EU contribution
€3,409,973
Participants
7
Scheme
MSCA-ITN

Lines connect the coordinator with its partners.

Results in brief

Tuning Tubulin Dynamics and Interactions to Face Neurotoxicity: a Multidisciplinary Approach for Training and Research

The improvements in life expectancy in the Western societies have turned neurodegenerative diseases and cancer into the most common health problems of the European Union. It is therefore of outmost importance to find and optimize tools that can contribute to the full comprehension of the molecular mechanisms involved in the progression of these pathologies. Microtubules a) are formed by polymerization of the globular proteins alpha- and beta-tubulin; b) present a structure that is regulated by a polymerization-depolymerization dynamic process; c) are biological entities that play an important role in a number of cellular processes including also cell division; d) interact with other proteins and this interaction is relevant for different cellular functionalities such as neuronal activity. Changes in the behaviour and organization of microtubules are emerging as relevant events associated with many neurodegenerative diseases. Deciphering the very basic biological mechanisms of neuronal damage linked to tubulin/microtubule perturbation is a challenge for facing neurodegeneration and in particular for the design of possible compounds that could reduce the effect of the neurological diseases. The aim of TubInTrain was to investigate the role of microtubules in neuron functionality through an interdisciplinary approach that is mandatory for a better comprehension of microtubules involvement in the pathogenic mechanisms of neurodegeneration. TubInTrain involved research groups that belongs to different scientific area such as chemistry, biology and computer science (Fig.1). All the scientific progresses in this subject, are giving important information for the design of therapeutic interventions, thus making this project in line with the aim of Horizon 2020 programme [Challenge “Health, demographic change and wellbeing”]. In particular, we investigated different strategies for tuning tubulin dynamics and the interactions of microtubules with other proteins with the aim to: i) model and evaluate the impact of different classes of small molecules (obtained by chemical synthesis or extracted by natural sources as secondary metabolites) on tubulin/microtubules at atomic level in cell free system, ii) model and evaluate the impact of two tubulin interacting proteins (Tau and alpha-Synuclein) on tubulin/microtubules at atomic level in cell free system, iii) determine the effects of the above compounds on microtubule dynamics, protein-microtubule interaction, protein aggregation and metabolism in peripheral neurons and in cellular models of neurodegeneration. The research activities were articulated into three Work Packages (WP1-WP2-WP3 - Fig.2)

Data: CORDIS, © European Union

Project objective

TubInTrain is a Consortium of 7 beneficiaries and 14 partners from 6 European countries joining their forces to train 13 Early Stage Researchers (ESRs) for n European Joint Doctorate.TubInTrain mission is to:- develop an Elite European Doctorate School to train ESRs in the context of neurodegeneration as well as in essential scientific, entrepreneurial and management skills;- create a multidisciplinary and multi-sectorial network for long-term cooperation in the research training of internationally oriented scientists for the global workplace;- train a new generation of cutting-edge researchers/professionals for employment by highly attractive European Institutions.The ESRs will work on an integrated innovative research project focused on the microtubules breakdown associated to neurodegenerative diseases and neurotoxicity. Despite the constant improvement in medical treatments, a significant leap in therapies for such diseases has been lacking for a long time. This calls for an ever-renewing effort in the investigation of their basic pathological mechanisms. This objective will be achieved through fertile collaborations between the partners, which have diverse expertise, ranging from computational chemistry to neurobiology.The Consortium will manage the recruitment/supervision/assessment processes. Each ESR will be co-supervised by two Beneficiaries, delivering the double degree, and a Partner. Two secondments are planned to improve the ESR research and training programs with management skills. ESRs will benefit of lectures/Training Schools/Workshops integrating the local graduate programs. This process coaches ESRs to: rise to challenges, be flexible/adaptable, achieve valuable attributes for today’s knowledge-based environment, be ready for creative and leadership roles in industry/academy/public sectors. All the know-how built up among the Consortium will spread out to external groups through exposures, public engagement, network and outreach activities

Original text from CORDIS.

Participants

  • UNIVERSITA DEGLI STUDI DI MILANO · MilanoCoordinatorItaly
  • AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS · MadridSpain
  • PAUL SCHERRER INSTITUT · VILLIGEN PSISwitzerland
  • UNIVERSITAET OSNABRUECK · OsnabrueckGermany
  • UNIVERSITAT DE BARCELONA · BarcelonaSpain
  • UNIVERSITE DE STRASBOURG · StrasbourgFrance
  • UNIVERSITE PARIS-SACLAY · Gif-Sur-YvetteFrance

Links

Data: CORDIS, © European Union